𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalent mutations in prostate cancer

✍ Scribed by Jin-Tang Dong

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
139 KB
Volume
97
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Quantitative and structural genetic alterations cause the development and progression of prostate cancer. A number of genes have been implicated in prostate cancer by genetic alterations and functional consequences of the genetic alterations. These include the ELAC2 (HPC2), MSR1, and RNASEL (HPC1) genes that have germline mutations in familial prostate cancer; AR, ATBF1, EPHB2 (ERK), KLF6, mitochondria DNA, p53, PTEN, and RAS that have somatic mutations in sporadic prostate cancer; AR, BRCA1, BRCA2, CHEK2 (RAD53), CYP17, CYP1B1, CYP3A4, GSTM1, GSTP1, GSTT1, PON1, SRD5A2, and VDR that have germline genetic variants associated with either hereditary and/or sporadic prostate cancer; and ANXA7 (ANX7), KLF5, NKX3‐1 (NKX3.1), CDKN1B (p27), and MYC that have genomic copy number changes affecting gene function. More genes relevant to prostate cancer remain to be identified in each of these gene groups. For the genes that have been identified, most need additional genetic, functional, and/or biochemical examination. Identification and characterization of these genes will be a key step for improving the detection and treatment of prostate cancer. Β© 2005 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Androgen receptor gene mutations in horm
Androgen receptor gene mutations in hormone-refractory prostate cancer
✍ WallοΏ½n, Mika J.; Linja, Marika; Kaartinen, Kaius; Schleutker, Johanna; Visakorpi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

Prostate cancer is considered to be one of the most hormone-dependent human malignancies. As a key mediator of hormonal response, the androgen receptor (AR) is believed to have an important role in the progression of prostate cancer. Mutations in the coding region of the AR gene have been found in b

Mutational analysis of the TrkA gene in
Mutational analysis of the TrkA gene in prostate cancer
✍ George, Daniel J.; Suzuki, Hiroyoshi; Bova, G. Steven; Isaacs, John T. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 629 KB

## Background: Trka, the high affinity, tyrosine kinase receptor for nerve growth factor (ngf) has been implicated as an oncogene in several neoplasms. in prostate cancer, inhibitors of the ngf/trka signal pathway results in tumor growth inhibition. in contrast, inhibition of this trk pathway in th

BRCA2 mutation in a family with heredita
BRCA2 mutation in a family with hereditary prostate cancer
✍ Henrik GrΓΆnberg; Anna-Karin Γ…hman; Monica Emanuelsson; Anders Bergh; Jan-Erik Da πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views
Mutation and expression analysis of thep
Mutation and expression analysis of thep73 gene in prostate cancer
✍ Yokomizo, Akira; Mai, Ming; Bostwick, David G.; Tindall, Donald J.; Qian, Junqi; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 365 KB πŸ‘ 2 views

BACKGROUND. p53 is the most highly mutated tumor suppressor gene in human cancers. Recently, p73, a first homologue of p53, was identified and considered to be an imprinted tumor suppressor gene. Thus, we analyzed the possible role of p73 in human prostate cancers. METHODS. We investigated the expre